Kestra Medical Technologies, Ltd. (KMTS) stock
KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
$28.64+0.02 (+0.07%)
Close on Nov 13, 2026Market cap $1.71BP/E –Yield –
Kestra Medical Technologies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Kestra Medical Technologies's ebitda for the twelve months ending Jul 31, 2026 was -$134.18M. For fiscal 2026 it was -$126.03M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | -$126.03M | – |
| FY2025 | Apr 30, 2025 | -$98.41M | – |
| FY2024 | Apr 30, 2024 | -$73.50M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | -$34.99M | – |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | -$37.02M | – |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | -$32.78M | – |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | -$29.38M | – |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | -$26.85M | – |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | -$46.38M | – |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | -$18.71M | – |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | -$17.27M | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | -$16.06M | – |
See a number that looks wrong?